Express Scripts Holding Company (ESRX)

92.33
3.47 3.62
NASDAQ
Prev Close 95.80
Open 95.57
Day Low/High 92.11 / 95.87
52 Wk Low/High 66.93 / 101.73
Volume 31.61M
Exchange NASDAQ
Div & Yield N.A. (N.A)
When to Ignore the Bad News

When to Ignore the Bad News

Fallout from dispute with Anthem, its largest customer, presents an opportunity.

Express Scripts Holding Becomes #9 Most Shorted Nasdaq 100 Component, Replacing Charter Communications

The most recent short interest data has been released for the 04/13/2017 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the Nasdaq 100 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

Anthem CEO Talks Tough on Keeping Cigna Deal

Anthem CEO Talks Tough on Keeping Cigna Deal

On an earnings call Wednesday, Anthem's Joseph Swedish says his firm is committed to completing its acquisition of Cigna.

Analysts' Actions -- Arconic, Big Lots, Chipotle, Snap and More

Analysts' Actions -- Arconic, Big Lots, Chipotle, Snap and More

Here are Wednesday's top research calls, including downgrades for Chipotle and Arconic, an upgrade for Big Lots and new coverage of Snap.

IMPORTANT INVESTOR ALERT: Lundin Law PC Announces An Investigation Of Express Scripts Holding Company And Advises Investors With Losses To Contact The Firm

Lundin Law PC, a shareholder rights firm, announces that it is investigating claims against Express Scripts Holding Company ("Express Scripts" or the "Company") (Nasdaq: ESRX) concerning possible violations of...

Closing Bell: Nasdaq Settles Above 6,000 With New Record; McDonald's Boosts Dow

Closing Bell: Nasdaq Settles Above 6,000 With New Record; McDonald's Boosts Dow

The Nasdaq settles above its 6,000 milestone for the first time ever and scores a new record close by the end of the session.

Express Scripts Stock Sliding, Anthem Unlikely to Extend Agreement

Express Scripts Stock Sliding, Anthem Unlikely to Extend Agreement

Express Scripts is losing its largest customer.

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces An Investigation Involving Possible Securities Fraud Violations By Certain Officers And Directors Of Express Scripts Holding Company

Levi & Korsinsky, LLP announces it has commenced an investigation of Express Scripts Holding Company ("Express Scripts") (NASDAQ:ESRX) concerning possible violations of federal securities laws.

Stocks Hold at Highs as Dow, S&P 500 Enjoy Best Two-Day Stretch of 2017

Stocks Hold at Highs as Dow, S&P 500 Enjoy Best Two-Day Stretch of 2017

Better-than-expected earnings from industry leaders including Caterpillar and McDonald's push the Dow to log triple-digit gains for the second day in a row, its best two-day stretch of the year.

SHAREHOLDER ALERT: Khang & Khang LLP Announces An Investigation Of Express Scripts Holding Company And Encourages Investors With Losses To Contact The Firm

Khang & Khang LLP (the "Firm") announces that it is investigating claims against Express Scripts Holding Company ("Express Scripts" or the "Company") (Nasdaq: ESRX) concerning possible violations of federal securities...

5 Things You Must Know Before the Market Opens Monday

5 Things You Must Know Before the Market Opens Monday

U.S. stock futures are set for solid gains and European stocks soar after the first round of France's elections put centrist Emmanuel Macron in the lead for the presidency.

Market Recon: The World Is Agog With 'Risk-on' Behavior

Market Recon: The World Is Agog With 'Risk-on' Behavior

But also remember that this week earnings will run wild, with nearly 200 members of the S&P 500 reporting.

Wake Up Wall Street: Centrist Emmanuel Macron in the Driver's Seat to Enter the Elysee Palace

Wake Up Wall Street: Centrist Emmanuel Macron in the Driver's Seat to Enter the Elysee Palace

Here are five things you must know for Monday, April 24.

Week Ahead: Earnings Come in Thick and Fast in a Middling First-Quarter Reporting Season

Week Ahead: Earnings Come in Thick and Fast in a Middling First-Quarter Reporting Season

Full-steam ahead for earnings season in the coming week as a range of industry leaders across a swath of sectors release their recent quarterly performances.

Express Scripts: A Prescription for Value

Express Scripts: A Prescription for Value

Its earnings are more than double what they were five years ago, but the stock price is the same.

Politicians Question EpiPen Competitor's High Pricetag

Politicians Question EpiPen Competitor's High Pricetag

Chuck Grassley is hammering the privately held drug company on its $4,500 EpiPen competitor.

Market Recon: President Trump's Speech Will Dominate Trading

Market Recon: President Trump's Speech Will Dominate Trading

I believe this president goes full Trumpian tonight, in a style that he has made all his own.

Here's Why AmerisourceBergen Is Up 16% This Year

Here's Why AmerisourceBergen Is Up 16% This Year

The pharmaceutical distributor is finally turning around.

What We Need to Know: Express Scripts Q4 Earnings

What We Need to Know: Express Scripts Q4 Earnings

It used the earning's call to pass much of the blame for high drug prices onto pharmaceutical companies.

Express Scripts: Rx For Earnings Growth

Express Scripts: Rx For Earnings Growth

The country's largest pharmacy benefits manager is enjoying tailwinds after reporting a big jump in year-over-year profits.

Express Scripts Officials Use Earnings Call to Blame Pharma for Drug Pricing

Express Scripts Officials Use Earnings Call to Blame Pharma for Drug Pricing

The pharmacy benefit manager shifted blame for drug pricing back to pharma companies.

How Kaleo Pharma Prices Its EpiPen Competitor

How Kaleo Pharma Prices Its EpiPen Competitor

Kaleo's EpiPen compeitor the Auvi-Q was released today.

Mylan Shares Unchanged as Kaleo Releases EpiPen Competitor

Mylan Shares Unchanged as Kaleo Releases EpiPen Competitor

The Auvi-Q was released Feb. 14, but it's unclear whether patients will break up with their current option, EpiPen, for something new.

Bearish Bets: A PBM, a Regional Airline and Other Stocks That Look Good Short

BLL, OPK, ESRX, SKYW and DLA all were recently downgraded by TheStreet's Quant Ratings.

Barclays, Banco Santander, Amgen, UnitedHealth Group: 'Mad Money' Lightning Round

Barclays, Banco Santander, Amgen, UnitedHealth Group: 'Mad Money' Lightning Round

Jim Cramer likes European banks, plus Banco Santander, and New York Community Bancorp, too.

Analyzing Risks Posed by a Possible Trump Correction: Cramer's 'Mad Money' Recap (Tuesday 2/7/17)

Analyzing Risks Posed by a Possible Trump Correction: Cramer's 'Mad Money' Recap (Tuesday 2/7/17)

Jim Cramer takes a closer look at the risks: Don't measure 'Trump per share,' measure actual earnings per share.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AG, AMZN, CBPX, CTLT, FSM, GOLD, LADR, OHI Downgrades: ESRX, GCO, NXPI, OPB, PIP, RDY, TM Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

The S&P 500 Companies With the Most Diverse Boards

The S&P 500 Companies With the Most Diverse Boards

The most ethnically and gender diverse boards may surprise you.